Mr. Anil Saxena

Group CFO

 

Mr. Anil Saxena has been Group Chief Finance Officer of Religare Enterprises Limited since April 2007. Mr. Saxena served as the Chief Financial Officer at Religare Securities Limited. He carries the overall responsibility for management and supervision of RSL and played a key role in driving its growth. He joined RSL on August 1, 2001. He has over 20 years of experience in the financial services industry.

 

He served as Managing Director of Religare Finvest Limited until November 14, 2011. He served as a Vice President at Kotak Securities Limited. He also worked with Fortis Financial Services Limited and R. Singhania & Co. He has been a Non Executive Director of Religare Technova Global Solutions Ltd., since October 29, 2007. He has been a Director of Religare Finvest Limited since April 6, 2010. He served as a Director of Religare Enterprises Limited from April 6, 2010 to January 24, 2013.

 

Mr. Saxena serves as a Director of Religare Aviation Ltd., Religare Arts Initiative Limited; Religare Travels (India) Limited; Ran Air Services Limited; Religare United Soccer Limited; Medsource Health Care Private Limited; Religare Arts Investment Management Limited; Religare Technova IT Services Limited; Religare Capital Markets Limited; Religare Securities Limited; SAK Consumer Retail Services Limited; Life Time Health Care Private Limited; Pill and Powder Private Limited; Religare Capital Markets International (Mauritius) Ltd.; Religare Capital Markets International (UK) Ltd.; Religare Hichens, Harrison plc; and Religare Hichens Harrison Inc.

 

He serves as Associate Director of Religare Invesco Asset Management Company Private Limited. He served as a Director at Religare Wellness Limited. He served as Director of Religare Technologies Ltd. until October 11, 2010. Mr. Saxena is also a member of the Institute of Chartered Accountants of India and Institute of the Cost and Works Accountants of India. He received a Bachelor's degree in Commerce from the University of Delhi.

toilax rektal suspension toilax 5 mg toilax klysma
Linkedin: